110 related articles for article (PubMed ID: 12482640)
1. Acarbose in the treatment of elderly patients with type 2 diabetes.
Josse RG; Chiasson JL; Ryan EA; Lau DC; Ross SA; Yale JF; Leiter LA; Maheux P; Tessier D; Wolever TM; Gerstein H; Rodger NW; Dornan JM; Murphy LJ; Rabasa-Lhoret R; Meneilly GS
Diabetes Res Clin Pract; 2003 Jan; 59(1):37-42. PubMed ID: 12482640
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas.
Lin BJ; Wu HP; Huang HS; Juang JH; Sison A; bin Abdul Kadir DK; Cho CG; Sridama W;
J Diabetes Complications; 2003; 17(4):179-85. PubMed ID: 12810240
[TBL] [Abstract][Full Text] [Related]
3. Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
Meneilly GS; Ryan EA; Radziuk J; Lau DC; Yale JF; Morais J; Chiasson JL; Rabasa-Lhoret R; Maheux P; Tessier D; Wolever T; Josse RG; Elahi D
Diabetes Care; 2000 Aug; 23(8):1162-7. PubMed ID: 10937515
[TBL] [Abstract][Full Text] [Related]
4. Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.
Pan C; Yang W; Barona JP; Wang Y; Niggli M; Mohideen P; Wang Y; Foley JE
Diabet Med; 2008 Apr; 25(4):435-41. PubMed ID: 18341596
[TBL] [Abstract][Full Text] [Related]
5. Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin.
Phillips P; Karrasch J; Scott R; Wilson D; Moses R
Diabetes Care; 2003 Feb; 26(2):269-73. PubMed ID: 12547847
[TBL] [Abstract][Full Text] [Related]
6. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of acarbose in type 2 diabetes mellitus in Jamaica.
Morrison EY; Wright-Pascoe R; Aquart A; Robinson H; Banbury M; Whitbourne F; Callender J; Less L; Bailey S
West Indian Med J; 2000 Dec; 49(4):285-9. PubMed ID: 11211536
[TBL] [Abstract][Full Text] [Related]
8. An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group.
Chan JC; Chan KW; Ho LL; Fuh MM; Horn LC; Sheaves R; Panelo AA; Kim DK; Embong M
Diabetes Care; 1998 Jul; 21(7):1058-61. PubMed ID: 9653595
[TBL] [Abstract][Full Text] [Related]
9. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
Gentile S; Turco S; Guarino G; Oliviero B; Rustici A; Torella R
Ann Ital Med Int; 1999; 14(1):7-14. PubMed ID: 10528419
[TBL] [Abstract][Full Text] [Related]
10. RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.
Derosa G; Maffioli P; D'Angelo A; Fogari E; Bianchi L; Cicero AF
J Diabetes Complications; 2011; 25(4):258-66. PubMed ID: 21367625
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.
Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Fogari E; Salvadeo SA; Ferrari I; Gravina A; Fassi R; Fogari R
Clin Drug Investig; 2006; 26(9):529-39. PubMed ID: 17163286
[TBL] [Abstract][Full Text] [Related]
12. Is acarbose equivalent to tolbutamide as first treatment for newly diagnosed type 2 diabetes in general practice? A randomised controlled trial.
van de Laar FA; Lucassen PL; Kemp J; van de Lisdonk EH; van Weel C; Rutten GE
Diabetes Res Clin Pract; 2004 Jan; 63(1):57-65. PubMed ID: 14693413
[TBL] [Abstract][Full Text] [Related]
13. Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study.
Hwu CM; Ho LT; Fuh MM; Siu SC; Sutanegara D; Piliang S; Chan JC;
Diabetes Res Clin Pract; 2003 May; 60(2):111-8. PubMed ID: 12706319
[TBL] [Abstract][Full Text] [Related]
14. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
15. European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses.
Fischer S; Hanefeld M; Spengler M; Boehme K; Temelkova-Kurktschiev T
Acta Diabetol; 1998 Apr; 35(1):34-40. PubMed ID: 9625287
[TBL] [Abstract][Full Text] [Related]
16. Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.
Hanefeld M; Haffner SM; Menschikowski M; Koehler C; Temelkova-Kurktschiev T; Wildbrett J; Fischer S
Diabetes Res Clin Pract; 2002 Mar; 55(3):221-7. PubMed ID: 11850098
[TBL] [Abstract][Full Text] [Related]
17. Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes.
Mughal MA; Memon MY; Zardari MK; Tanwani RK; Ali M
J Pak Med Assoc; 2000 May; 50(5):152-6. PubMed ID: 11242714
[TBL] [Abstract][Full Text] [Related]
18. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
19. Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.
Schnell O; Mertes G; Standl E;
Diabetes Obes Metab; 2007 Nov; 9(6):853-8. PubMed ID: 17924867
[TBL] [Abstract][Full Text] [Related]
20. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
